secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0001213900-22-008245
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron appoints Todd Girolamo to Board of Directors
-------------------------------------------------------

- Girolamo appointed as Class II Director effective February 15, 2022; term expires at 2023 annual meeting.
- He will serve on the Audit Committee and receive a grant of 5,000 shares of Class A common stock (vesting) plus pro-rated cash retainer.
- Girolamo is Chief Legal Officer and SVP of Corporate Development at Caladrius Biosciences (NASDAQ: CLBS).
- No arrangements or transactions requiring Item 404(a) disclosure were reported.
- Board size unchanged; appointment adds legal, finance, and M&A expertise for Lomecel-B development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/0001213900-22-008245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/ea155885-8k_longeveron.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-008245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer